SLC5A5 and differentiated thyroid carcinoma: Since then, millions of patients, particularly ones with differentiated thyroid carcinoma, have been effectively treated with radioiodine, due to the high affinity of the iodide ion (I−) for a transmembrane glycoprotein expressed at the surface of thyroid cells, the sodium/iodide symporter (NIS) [1].